MoneyWorks4Me

Syncom Formulations (India) informs about certificate

05 Apr 2024 Evaluate

Syncom Formulations (India) has informed that it enclosed Certificate for Compliances as per Regulations 7(2) and 7(3) of the SEBI (LODR) Regulations, 2015 duly signed by the Compliance Officer and Company Secretary of the Company and Authorized Representative/Compliance Officer of the Share Transfer Agent -Ankit Consultancy of the Company for the Year ended on 31st March, 2024.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..